Thursday, 31 December 2009

Cefotaxime Sodium




Ingredient matches for Cefotaxime Sodium



Cefotaxime

Cefotaxime Sodium (BANM, USAN) is known as Cefotaxime in the US.



Desmopressin

Desmopressin is reported as an ingredient of Cefotaxime Sodium in the following countries:


  • Israel

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 26 December 2009

Calcianta




Calcianta may be available in the countries listed below.


Ingredient matches for Calcianta



Nifedipine

Nifedipine is reported as an ingredient of Calcianta in the following countries:


  • Indonesia

International Drug Name Search

Tuesday, 1 December 2009

Solvazinc




Solvazinc may be available in the countries listed below.


UK matches:

  • Solvazinc (SPC)

Ingredient matches for Solvazinc



Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Solvazinc in the following countries:


  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, 26 November 2009

Locacorten-Vioform




Locacorten-Vioform may be available in the countries listed below.


Ingredient matches for Locacorten-Vioform



Clioquinol

Clioquinol is reported as an ingredient of Locacorten-Vioform in the following countries:


  • Australia

  • Canada

  • Denmark

  • Germany

  • Netherlands

  • Sweden

Flumetasone

Flumetasone 21-pivalate (a derivative of Flumetasone) is reported as an ingredient of Locacorten-Vioform in the following countries:


  • Australia

  • Canada

  • Denmark

  • Germany

  • Netherlands

  • Sweden

International Drug Name Search

Thursday, 19 November 2009

Exocin




Exocin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Exocin
  • Exocin (SPC)

Ingredient matches for Exocin



Ofloxacin

Ofloxacin is reported as an ingredient of Exocin in the following countries:


  • Denmark

  • Finland

  • Greece

  • Ireland

  • Italy

  • Portugal

  • South Africa

  • Spain

  • Turkey

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, 11 November 2009

Atenololo Angenerico




Atenololo Angenerico may be available in the countries listed below.


Ingredient matches for Atenololo Angenerico



Atenolol

Atenolol is reported as an ingredient of Atenololo Angenerico in the following countries:


  • Italy

International Drug Name Search

Sunday, 8 November 2009

Skizon-N




Skizon-N may be available in the countries listed below.


Ingredient matches for Skizon-N



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Skizon-N in the following countries:


  • Indonesia

Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Skizon-N in the following countries:


  • Indonesia

International Drug Name Search

Wednesday, 4 November 2009

Cefotaxim-Tchaikapharma




Cefotaxim-Tchaikapharma may be available in the countries listed below.


Ingredient matches for Cefotaxim-Tchaikapharma



Cefotaxime

Cefotaxime sodium salt (a derivative of Cefotaxime) is reported as an ingredient of Cefotaxim-Tchaikapharma in the following countries:


  • Bulgaria

International Drug Name Search

Monday, 2 November 2009

Zevert




Zevert may be available in the countries listed below.


Ingredient matches for Zevert



Betahistine

Betahistine dihydrochloride (a derivative of Betahistine) is reported as an ingredient of Zevert in the following countries:


  • Myanmar

International Drug Name Search

Monday, 26 October 2009

Ibuprofeno Dermogeneris




Ibuprofeno Dermogeneris may be available in the countries listed below.


Ingredient matches for Ibuprofeno Dermogeneris



Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno Dermogeneris in the following countries:


  • Spain

International Drug Name Search

Tuesday, 13 October 2009

Guanfacine Hydrochloride




Guanfacine Hydrochloride may be available in the countries listed below.


Ingredient matches for Guanfacine Hydrochloride



Guanfacine

Guanfacine Hydrochloride (BANM, JAN, USAN) is known as Guanfacine in the US.

International Drug Name Search

Glossary

BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 10 October 2009

Ticlopidina DOC




Ticlopidina DOC may be available in the countries listed below.


Ingredient matches for Ticlopidina DOC



Ticlopidine

Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Ticlopidina DOC in the following countries:


  • Italy

International Drug Name Search

Tuesday, 6 October 2009

Mifamurtide




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AX15

CAS registry number (Chemical Abstracts Service)

0083461-56-7

Chemical Formula

C59-H109-N6-O19-P

Molecular Weight

1237

Therapeutic Categories

Antineoplastic agent

Immunomodulator

Chemical Name

2-[N-{(2R)-[(2-acetamido-2,3-dideoxy-D-glucopyranos-3-yl)oxy]propanoyl}-L-alanyl-D-isoglutaminyl-L-alanyl)amino]ethyl (2R)-2,3-bis(hexadecanoyloxy)propyl hydrogen phosphate (WHO)

Foreign Names

  • Mifamurtidum (Latin)
  • Mifamurtid (German)
  • Mifamurtide (French)
  • Mifamurtida (Spanish)

Generic Names

  • Cgp-19835A (IS)
  • MLV 19835 A (IS)
  • MTP-PE (IS)
  • Muramyl tripeptide phosphatidyl ethanolamine (IS)

Brand Names

  • MEPACT
    IDM Pharma SA, Germany; Takeda, United Kingdom

International Drug Name Search

Glossary

ISInofficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 3 October 2009

Depakene


Generic Name: valproic acid (val PRO ik A sid)

Brand Names: Depakene, Stavzor


What is Depakene (valproic acid)?

Valproic acid affects chemicals in the body that may be involved in causing seizures.


Valproic acid is used to treat various types of seizure disorders. Valproic acid is sometimes used together with other seizure medications.


Valproic acid may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Depakene (valproic acid)?


Valproic acid may cause harm to an unborn baby, but having a seizure during pregnancy could harm both the mother and the baby.

Valproic acid may also affect cognitive development in children born to mothers who take this medication during pregnancy. Studies have shown that these children may score lower on cognitive tests (reasoning, intelligence, and problem-solving) than children whose mothers took other seizure medications during pregnancy.


Tell your doctor right away if you become pregnant while taking valproic acid for seizures. Do not start or stop taking valproic acid during pregnancy without your doctor's advice. In rare cases, valproic acid has caused life-threatening liver failure, especially in children younger than 2 years old.

Valproic acid has also caused rare cases of life-threatening pancreatitis (inflammation of the pancreas). Pancreatitis can come on suddenly and symptoms may start even after you have been taking valproic acid for several years.


Seek emergency medical attention if the person taking this medicine has nausea, vomiting, upper stomach pain, or loss of appetite, low fever, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). These symptoms may be early signs of liver damage. Some of these symptoms may also be early signs of pancreatitis.

You may have thoughts about suicide while taking this medication. Your doctor will need to check you at regular visits. Do not miss any scheduled appointments.


Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, depression, anxiety, or if you feel agitated, hostile, restless, hyperactive (mentally or physically), or have thoughts about suicide or hurting yourself.

What should I discuss with my healthcare provider before taking Depakene (valproic acid)?


In rare cases, valproic acid has caused life-threatening liver failure, especially in children younger than 2 years old. Children of this age may be at even greater risk for liver problems if they use more than one seizure medication, if they have a metabolic disorder, or if they have a brain disease causing mental impairment (such as Creutzfeldt-Jacob disease, Huntington disease, multiple sclerosis, or a brain injury or infection). Valproic acid has also caused rare cases of life-threatening pancreatitis (inflammation of the pancreas). Pancreatitis can come on suddenly and symptoms may start even after you have been taking valproic acid for several years. Do not take valproic acid if you have liver disease or a urea cycle disorder. You should not take this medication if you are allergic to valproic acid, or if you have severe liver disease or a urea cycle disorder.

To make sure you can safely take valproic acid, tell your doctor if you have any of these other conditions:



  • liver disease;




  • a bleeding or blood clotting disorder;




  • a history of head injury, brain disorder, or coma;




  • a family history of a urea cycle disorder;




  • a family history of infant deaths with unknown cause; or




  • HIV or CMV (cytomegalovirus) infection.



Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits. Do not miss any scheduled appointments.


You may have thoughts about suicide while taking this medication. Tell your doctor if you have new or worsening depression or suicidal thoughts during the first several months of treatment, or whenever your dose is changed.


FDA pregnancy category D. Valproic acid can cause birth defects. Do not start taking valproic acid without telling your doctor if you are pregnant or planning to become pregnant. Use effective birth control while you are taking valproic acid.

Valproic acid may also affect cognitive development in children born to mothers who take this medication during pregnancy. Studies have shown that these children may score lower on cognitive tests (reasoning, intelligence, and problem-solving) than children whose mothers took other seizure medications during pregnancy.


Although valproic acid may harm an unborn baby, having a seizure during pregnancy could harm both mother and baby. If you become pregnant while taking valproic acid, do not stop taking the medicine without your doctor's advice. Seizure control is very important during pregnancy. The benefit of preventing seizures may outweigh any risks posed by taking valproic acid. There may be other seizure medications that can be more safely used during pregnancy. Follow your doctor's instructions about taking valproic acid while you are pregnant. Valproic acid can pass into breast milk and may harm a nursing baby. You should not breast-feed while you are using valproic acid.

How should I take Depakene (valproic acid)?


Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Drink plenty of water while you are taking this medication. Your dose may need to be changed if you do not get enough fluids each day.

Measure liquid medicine with a special dose measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose measuring device, ask your pharmacist for one.


To be sure this medication is not causing harmful effects, your liver function will need to be tested often. Visit your doctor regularly.


Do not stop using valproic acid without first talking to your doctor, even if you feel fine. You may have increased seizures if you stop using valproic acid suddenly. You may need to use less and less before you stop the medication completely. Swallow the capsule whole. Do not crush, chew, or break a capsule because the medicine may irritate your mouth or throat when you swallow it. Wear a medical alert tag or carry an ID card stating that you take valproic acid. Any medical care provider who treats you should know that you are taking a seizure medication. Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include sleepiness or drowsiness, shallow breathing, weak pulse, or loss of consciousness.


What should I avoid while taking Depakene (valproic acid)?


Drinking alcohol can increase certain side effects of valproic acid. Valproic acid may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Avoid exposure to sunlight or tanning beds. Valproic acid can make you sunburn more easily. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outdoors.

Depakene (valproic acid) side effects


Seek emergency medical attention if the person taking this medicine has nausea, vomiting, upper stomach pain, or loss of appetite, low fever, dark urine, clay-colored stools, or jaundice (yellowing of the skin or eyes). These symptoms may be early signs of liver damage. Some of these symptoms may also be early signs of pancreatitis.

Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these other serious side effects:

  • unexplained weakness with vomiting and confusion or fainting;




  • easy bruising or bleeding, blood in your urine;




  • fever, chills, body aches, swollen glands, flu symptoms;




  • urinating less than usual;




  • hallucinations (seeing things that aren't there);




  • extreme drowsiness, lack of coordination;




  • double vision or back-and-forth movements of the eyes; or




  • severe skin reaction -- fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.



Less serious side effects may include:



  • mild drowsiness or weakness;




  • diarrhea, constipation, upset stomach;




  • changes in your menstrual periods;




  • enlarged breasts;




  • tremor (shaking);




  • hair loss;




  • weight changes;




  • vision changes; or




  • unusual or unpleasant taste in your mouth.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Depakene (valproic acid)?


Cold or allergy medicine, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for depression or anxiety can add to sleepiness caused by valproic acid. Tell your doctor if you regularly use any of these medicines, or any other seizure medication.

Tell your doctor about all other medications you use, especially:



  • topiramate (Topamax);




  • tolbutamide (Orinase);




  • a blood thinner such as warfarin (Coumadin, Jantoven);




  • aspirin or acetaminophen (Tylenol);




  • zidovudine (Retrovir);




  • clozapine (Clozaril, FazaClo);




  • diazepam (Valium);




  • meropenem (Merrem) or imipenem and cilastatin (Primaxin);




  • rifampin (Rifadin, Rimactane, Rifater); or




  • ethosuximide (Zarontin).



This list is not complete and other drugs may interact with valproic acid. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Depakene resources


  • Depakene Side Effects (in more detail)
  • Depakene Use in Pregnancy & Breastfeeding
  • Drug Images
  • Depakene Drug Interactions
  • Depakene Support Group
  • 3 Reviews for Depakene - Add your own review/rating


  • Depakene Advanced Consumer (Micromedex) - Includes Dosage Information

  • Depakene MedFacts Consumer Leaflet (Wolters Kluwer)

  • Depakene Prescribing Information (FDA)

  • Valproic Acid Monograph (AHFS DI)

  • Depacon Prescribing Information (FDA)

  • Depacon Advanced Consumer (Micromedex) - Includes Dosage Information

  • Depacon MedFacts Consumer Leaflet (Wolters Kluwer)

  • Stavzor Prescribing Information (FDA)

  • Stavzor Delayed-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)

  • Stavzor Consumer Overview



Compare Depakene with other medications


  • Bipolar Disorder
  • Hyperekplexia
  • Schizoaffective Disorder
  • Seizure Prevention
  • Seizures


Where can I get more information?


  • Your pharmacist can provide more information about valproic acid.

See also: Depakene side effects (in more detail)


Sunday, 27 September 2009

Rinosoro




Rinosoro may be available in the countries listed below.


Ingredient matches for Rinosoro



Benzalkonium Chloride

Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Rinosoro in the following countries:


  • Brazil

International Drug Name Search

Biperiden




In the US, Biperiden (biperiden systemic) is a member of the drug class anticholinergic antiparkinson agents and is used to treat Extrapyramidal Reaction and Parkinson's Disease.

US matches:

  • Biperiden

  • Biperiden Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04AA02

CAS registry number (Chemical Abstracts Service)

0000514-65-8

Chemical Formula

C21-H29-N-O

Molecular Weight

311

Therapeutic Category

Treatment of Parkinson's disease: Central anticholinergic

Chemical Names

1-Piperidinepropanol, α-bicyclo[2.2.1]hept-5-en-2-yl-α-phenyl-

α-5-Norbornen-2-yl-α-phenyl-1-piperidinepropanol (WHO)

Foreign Names

  • Biperidenum (Latin)
  • Biperiden (German)
  • Bipéridène (French)
  • Biperideno (Spanish)

Generic Names

  • Biperiden (OS: JAN, BAN)
  • Biperidene (OS: DCIT)
  • Bipéridène (OS: DCF)
  • KL 373 (IS)
  • Biperiden (PH: USP 32, Ph. Int. 4)
  • Biperidenum (PH: Ph. Int. 4)
  • Biperiden Hydrochloride (OS: BANM, JAN, USAN)
  • Biperiden Hydrochloride (PH: BP 2010, Ph. Eur. 6, Ph. Int. 4, USP 32, JP XV)
  • Bipéridène (chlorhydrate de) (PH: Ph. Eur. 6)
  • Biperidenhydrochlorid (PH: Ph. Eur. 6)
  • Biperideni hydrochloridum (PH: Ph. Int. 4, Ph. Eur. 6)
  • Biperiden Lactate (OS: BANM)
  • Biperiden Lactate Injection (PH: USP 32)

Brand Names

  • Akinestat
    Tchaikapharma, Bulgaria


  • Akineton LP
    Abbott, Tunisia


  • Akineton Retard
    Abbott, Peru


  • Akineton
    Dainippon Sumitomo, Japan; Desma, Bulgaria; Desma, Portugal; Desma, Slovenia; Ebewe, Poland


  • Akiriden
    Kyowa Yakuhin, Japan


  • Benzum
    Carrion, Peru


  • Bicamol
    Sawai Seiyaku, Japan


  • Biperideno Northia
    Northia, Argentina


  • Biperideno Vannier
    Vannier, Argentina


  • Biperideno
    AC Farma, Peru; Hersil, Peru; Perugen, Peru


  • Mendilex
    Alkaloid, Bosnia & Herzegowina; Alkaloid, Serbia; Alkaloid, Slovenia


  • Tasmolin
    Tanabe Mitsubishi, Japan


  • Akineton LP
    DB, France


  • Akineton SR
    Knoll, Poland


  • Akineton
    Abbott, Argentina; Abbott, Chile; Abbott, Colombia; Abbott, Costa Rica; Abbott, Estonia; Abbott, Guatemala; Abbott, Honduras; Abbott, Jordan; Abbott, Lebanon; Abbott, Lithuania; Abbott, Latvia; Abbott, Nicaragua; Abbott, Panama; Abbott, Peru; Abbott, Philippines; Abbott, Poland; Abbott, Romania; Abbott, Serbia; Abbott, Saudi Arabia; Abbott, El Salvador; Abbott, Turkey; Abbott, Taiwan; Abbott, United States; Abbott, Venezuela; Desma, Austria; Desma, Bosnia & Herzegowina; Desma, Switzerland; Desma, Germany; Desma, Spain; Desma, Croatia (Hrvatska); Desma, Luxembourg; Desma, Russian Federation; Desma GmBh, Greece; EU-Pharma, Netherlands; Knoll, Brazil; Knoll, Slovakia; Laboratorio Farmaceutico, Denmark; Laboratorio Farmaceutico, Finland; Laboratorio Farmaceutico, Hungary; Laboratorio Farmaceutico, Ireland; Laboratorio Farmaceutico, Netherlands; Laboratorio Farmaceutico SIT, Czech Republic; Link, Australia; Pharmacobel, Belgium; S.I.T., Iceland; S.I.T., Norway; SIT, Italy; SIT, Italy; SIT, Sweden


  • Berofin
    Sanofi-Aventis, Argentina


  • Biperiden TAD
    TAD, Germany


  • Biperiden-neuraxpharm
    Neuraxpharm, Germany


  • Biperideno Cevallos
    Cevallos, Argentina


  • Biperideno Dosa
    Dosa, Argentina


  • Biperideno Duncan
    Duncan, Argentina


  • Biperideno MK
    MK, Colombia


  • Biperideno Rospaw
    Rospaw, Argentina


  • Biperin
    Union Lab, Taiwan


  • Dekinet
    Rafa, Israel


  • Denzolam
    Denver, Argentina


  • Dyskinon
    Nicholas, India


  • Ipsatol
    Orion, Finland


  • Kinex
    Psicofarma, Mexico


  • Mendilex
    Alkaloid, Croatia (Hrvatska)


  • Sinekin
    Fabop, Argentina


  • Akineton
    Abbott, Costa Rica; Abbott, Guatemala; Abbott, Honduras; Abbott, Latvia; Abbott, Nicaragua; Abbott, Panama; Abbott, Peru; Abbott, Romania; Abbott, Serbia; Abbott, El Salvador; Abbott, Turkey; Abbott, Venezuela; Desma, Austria; Desma, Bosnia & Herzegowina; Desma, Switzerland; Desma, Germany; Desma, Spain; Knoll, Slovakia; Knoll, United States; Laboratorio Farmaceutico, Hungary; Laboratorio Farmaceutico SIT, Czech Republic; S.I.T., Norway; SIT, Italy


  • Biperiden-neuraxpharm
    Neuraxpharm, Germany

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 19 September 2009

Iselpin




Iselpin may be available in the countries listed below.


Ingredient matches for Iselpin



Sucralfate

Sucralfate is reported as an ingredient of Iselpin in the following countries:


  • Philippines

International Drug Name Search

Wednesday, 16 September 2009

Oguzalot




Oguzalot may be available in the countries listed below.


Ingredient matches for Oguzalot



Ozagrel

Ozagrel sodium (a derivative of Ozagrel) is reported as an ingredient of Oguzalot in the following countries:


  • Japan

International Drug Name Search

Saturday, 5 September 2009

Triamterene / Hydrochlorothiazide




Ingredient matches for Triamterene / Hydrochlorothiazide



Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Triamterene / Hydrochlorothiazide in the following countries:


  • United States

Triamterene

Triamterene is reported as an ingredient of Triamterene / Hydrochlorothiazide in the following countries:


  • United States

International Drug Name Search

Thursday, 3 September 2009

Lambeta




Lambeta may be available in the countries listed below.


Ingredient matches for Lambeta



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Lambeta in the following countries:


  • Greece

International Drug Name Search

Monday, 31 August 2009

V-Cillin




V-Cillin may be available in the countries listed below.


Ingredient matches for V-Cillin



Pivmecillinam

Pivmecillinam is reported as an ingredient of V-Cillin in the following countries:


  • Bangladesh

International Drug Name Search

Kenzen




Kenzen may be available in the countries listed below.


Ingredient matches for Kenzen



Candesartan

Candesartan cilexetil (a derivative of Candesartan) is reported as an ingredient of Kenzen in the following countries:


  • France

International Drug Name Search

Thursday, 27 August 2009

Ciprokem




Ciprokem may be available in the countries listed below.


Ingredient matches for Ciprokem



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Ciprokem in the following countries:


  • Peru

International Drug Name Search

Sunday, 23 August 2009

Clorotrimeton




Clorotrimeton may be available in the countries listed below.


Ingredient matches for Clorotrimeton



Chlorphenamine

Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Clorotrimeton in the following countries:


  • Colombia

  • Venezuela

International Drug Name Search

Thursday, 20 August 2009

Glulo




Glulo may be available in the countries listed below.


Ingredient matches for Glulo



Glibenclamide

Glibenclamide is reported as an ingredient of Glulo in the following countries:


  • Indonesia

International Drug Name Search

Wednesday, 19 August 2009

Ciclosporin Sandoz




Ciclosporin Sandoz may be available in the countries listed below.


Ingredient matches for Ciclosporin Sandoz



Ciclosporin

Ciclosporin is reported as an ingredient of Ciclosporin Sandoz in the following countries:


  • Estonia

  • Latvia

  • Lithuania

International Drug Name Search

Tuesday, 18 August 2009

Sinaceph




Sinaceph may be available in the countries listed below.


Ingredient matches for Sinaceph



Cefradine

Cefradine is reported as an ingredient of Sinaceph in the following countries:


  • Bangladesh

  • Myanmar

International Drug Name Search

Thursday, 16 July 2009

Fegem




Fegem may be available in the countries listed below.


Ingredient matches for Fegem



Iron Polymaltose

Iron Polymaltose is reported as an ingredient of Fegem in the following countries:


  • Bahrain

  • Myanmar

International Drug Name Search

Wednesday, 15 July 2009

Folsäure Solvay




Folsäure Solvay may be available in the countries listed below.


Ingredient matches for Folsäure Solvay



Folic Acid

Folic Acid is reported as an ingredient of Folsäure Solvay in the following countries:


  • Austria

  • Germany

International Drug Name Search

Saturday, 4 July 2009

Carva




Carva may be available in the countries listed below.


Ingredient matches for Carva



Aspirin

Acetylsalicylic Acid is reported as an ingredient of Carva in the following countries:


  • Bangladesh

International Drug Name Search

Friday, 26 June 2009

Tolksiel




Tolksiel may be available in the countries listed below.


Ingredient matches for Tolksiel



Dilazep

Dilazep dihydrochloride (a derivative of Dilazep) is reported as an ingredient of Tolksiel in the following countries:


  • Japan

International Drug Name Search

Friday, 19 June 2009

Aciclovir Bestpharma




Aciclovir Bestpharma may be available in the countries listed below.


Ingredient matches for Aciclovir Bestpharma



Acyclovir

Aciclovir is reported as an ingredient of Aciclovir Bestpharma in the following countries:


  • Peru

International Drug Name Search

Thursday, 4 June 2009

Corodil




Corodil may be available in the countries listed below.


Ingredient matches for Corodil



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Corodil in the following countries:


  • Denmark

International Drug Name Search

Dapagut




Dapagut may be available in the countries listed below.


Ingredient matches for Dapagut



Paroxetine

Paroxetine mesilate (a derivative of Paroxetine) is reported as an ingredient of Dapagut in the following countries:


  • Italy

International Drug Name Search

Sunday, 17 May 2009

Vardolin




Vardolin may be available in the countries listed below.


Ingredient matches for Vardolin



Buflomedil

Buflomedil hydrochloride (a derivative of Buflomedil) is reported as an ingredient of Vardolin in the following countries:


  • Greece

International Drug Name Search

Cetirizina Clorhidrato




Cetirizina Clorhidrato may be available in the countries listed below.


Ingredient matches for Cetirizina Clorhidrato



Cetirizine

Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Cetirizina Clorhidrato in the following countries:


  • Peru

International Drug Name Search

Thursday, 14 May 2009

Asenapine




In the US, Asenapine (asenapine systemic) is a member of the drug class atypical antipsychotics and is used to treat Bipolar Disorder, Post Traumatic Stress Disorder, Schizoaffective Disorder and Schizophrenia.

US matches:

  • Asenapine

  • Asenapine Sublingual

  • Asenapine Maleate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AH05

CAS registry number (Chemical Abstracts Service)

0065576-45-6

Chemical Formula

C17-H16-Cl-N-O

Molecular Weight

285

Therapeutic Category

Central stimulant

Chemical Names

(3aR,12bR)-rel-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole

(3aRS,12bRS)-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole (WHO)

Foreign Names

  • Asenapinum (Latin)
  • Asenapin (German)
  • Asénapine (French)
  • Asenapina (Spanish)

Generic Names

  • Asenapine (OS: BAN)
  • UNII-JKZ19V908O (IS)
  • Asenapine maleate (OS: USAN)
  • Org 5222 (IS)
  • UNII-CU9463U2E2 (IS)

Brand Name

  • Saphris
    Schering-Plough, United States

International Drug Name Search

Glossary

BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 12 May 2009

Acetafen




Acetafen may be available in the countries listed below.


Ingredient matches for Acetafen



Paracetamol

Paracetamol is reported as an ingredient of Acetafen in the following countries:


  • Venezuela

International Drug Name Search

Monday, 11 May 2009

Losefan




Losefan may be available in the countries listed below.


Ingredient matches for Losefan



Alfacalcidol

Alfacalcidol is reported as an ingredient of Losefan in the following countries:


  • Greece

International Drug Name Search

Sunday, 10 May 2009

Uroleap




Uroleap may be available in the countries listed below.


Ingredient matches for Uroleap



Benzbromarone

Benzbromarone is reported as an ingredient of Uroleap in the following countries:


  • Japan

International Drug Name Search

Sunday, 26 April 2009

Camphoderm N




Camphoderm N may be available in the countries listed below.


Ingredient matches for Camphoderm N



Camphor

Camphor is reported as an ingredient of Camphoderm N in the following countries:


  • Germany

International Drug Name Search

Wednesday, 22 April 2009

Nu-Amoxi




Nu-Amoxi may be available in the countries listed below.


Ingredient matches for Nu-Amoxi



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Nu-Amoxi in the following countries:


  • Canada

International Drug Name Search

Sunday, 12 April 2009

Entereg




In the US, Entereg (alvimopan systemic) is a member of the drug class peripheral opioid receptor antagonists and is used to treat Gastrointestinal Surgery and Postoperative Ileus.

US matches:

  • Entereg

Ingredient matches for Entereg



Alvimopan

Alvimopan is reported as an ingredient of Entereg in the following countries:


  • United States

International Drug Name Search

Saturday, 4 April 2009

Os-Cal with D


Generic Name: calcium and vitamin D combination (KAL see um and VYE ta min D)

Brand Names: Calcarb with D, Calcet, Calcio Del Mar, Calcitrate with D, Calcium 600+D, Caltrate 600 with D, Caltrate 600 with D Plus Soy, Caltrate Colon Health, Citracal + D, Citracal 250 mg + D, Citracal Creamy Bites, Citracal Maximum + D, Citracal Petites, Citrus Calcium with Vitamin D, Dical-D, Os-Cal 250 with D, Os-Cal 500 + D, Os-Cal with D, Oysco 500 with D, Oysco D, Oyst-Cal-D, Oyster Shell Calcium with Vitamin D, Oyster-D, Oystercal-D, Posture-D H/P, Risacal-D


What is Os-Cal with D (calcium and vitamin D combination)?

Calcium is a mineral that is found naturally in foods. Calcium is necessary for many normal functions of your body, especially bone formation and maintenance.


Vitamin D is important for the absorption of calcium from the stomach and for the functioning of calcium in the body.


Calcium and vitamin D combination is used to prevent or to treat a calcium deficiency.


Calcium and vitamin D combination may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Os-Cal with D (calcium and vitamin D combination)?


Before you take calcium and vitamin D combination, tell your doctor if you have kidney disease, past or present kidney stones, heart disease, circulation problems, a parathyroid disorder, or if you are pregnant or breast-feeding.


Avoid taking any other vitamin or mineral supplements that contain calcium or vitamin D without first talking to your doctor.

Before taking calcium and vitamin D combination, tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.


What should I tell my healthcare provider before taking Os-Cal with D (calcium and vitamin D combination)?


If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take calcium and vitamin D combination, tell your doctor if you have:


  • kidney disease;

  • past or present kidney stones;


  • heart disease;




  • circulation problems; or




  • a parathyroid gland disorder.




Talk to your doctor before taking calcium and vitamin D combination if you are pregnant. Talk to your doctor before taking calcium and vitamin D combination if you are breast-feeding.

How should I take Os-Cal with D (calcium and vitamin D combination)?


Take this medication exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.


Take the calcium and vitamin D regular tablet with a full glass of water.

The chewable tablet should be chewed before you swallow it.


Store calcium and vitamin D combination at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to take the medicine and skip the missed dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include irregular heartbeat, stomach pain, nausea, vomiting, dry mouth, a metallic taste in your mouth, confusion, loss of appetite, constipation, weakness, headache, confusion, or fainting.


What should I avoid while taking Os-Cal with D (calcium and vitamin D combination)?


Avoid taking any other vitamin or mineral supplements that contain calcium or vitamin D without first talking to your doctor.

Os-Cal with D (calcium and vitamin D combination) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Less serious side effects may include:



  • an irregular heartbeat;




  • nausea, vomiting, or decreased appetite;




  • dry mouth;




  • constipation;




  • weakness;




  • headache;




  • a metallic taste;




  • muscle or bone pain; or




  • drowsiness.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Os-Cal with D (calcium and vitamin D combination)?


Before taking calcium and vitamin D combination, tell your doctor if you are taking:



  • digoxin (Lanoxin, Lanoxicaps);




  • antacids containing calcium, aluminum, or magnesium;




  • other calcium supplements;




  • calcitriol (Rocaltrol) or other vitamin D supplements; or




  • a tetracycline antibiotic such as demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap).



This list is not complete and there may be other drugs that can interact with calcium and vitamin D combination. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Os-Cal with D resources


  • Os-Cal with D Side Effects (in more detail)
  • Os-Cal with D Use in Pregnancy & Breastfeeding
  • Os-Cal with D Drug Interactions
  • Os-Cal with D Support Group
  • 0 Reviews for Os-Cal with D - Add your own review/rating


Compare Os-Cal with D with other medications


  • Dietary Supplementation
  • Osteoporosis


Where can I get more information?


  • Your pharmacist can provide more information about calcium and vitamin D combination.

See also: Os-Cal with D side effects (in more detail)


Friday, 27 March 2009

Ciatyl-Z Depot




Ciatyl-Z Depot may be available in the countries listed below.


Ingredient matches for Ciatyl-Z Depot



Zuclopenthixol

Zuclopenthixol decanoate (a derivative of Zuclopenthixol) is reported as an ingredient of Ciatyl-Z Depot in the following countries:


  • Germany

International Drug Name Search

Sunday, 15 March 2009

Sanquinone




Sanquinone may be available in the countries listed below.


Ingredient matches for Sanquinone



Ubidecarenone

Ubidecarenone is reported as an ingredient of Sanquinone in the following countries:


  • Japan

International Drug Name Search

Thursday, 12 March 2009

Kalii Iodidum




Kalii Iodidum may be available in the countries listed below.


Ingredient matches for Kalii Iodidum



Potassium Iodide

Potassium Iodide is reported as an ingredient of Kalii Iodidum in the following countries:


  • Bulgaria

International Drug Name Search

Monday, 9 March 2009

Razolager




Razolager may be available in the countries listed below.


Ingredient matches for Razolager



Lansoprazole

Lansoprazole is reported as an ingredient of Razolager in the following countries:


  • Ireland

International Drug Name Search

Tuesday, 3 March 2009

boceprevir


boe-SE-pre-vir


Commonly used brand name(s)

In the U.S.


  • Victrelis

Available Dosage Forms:


  • Capsule

Pharmacologic Class: Protease Inhibitor


Uses For boceprevir


Boceprevir is used in combination with injectable peginterferon alfa (Pegasys®, Pegintron®) and ribavirin (Copegus®, Rebetol®) to treat chronic hepatitis C infection. These medicines are used in patients with compensated liver disease (including cirrhosis), who have not been treated before or who have received other medicines but did not work well. Boceprevir is a direct-acting antiviral agent that treats hepatitis C infection.


boceprevir is available only with your doctor's prescription.


Before Using boceprevir


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For boceprevir, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to boceprevir or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of boceprevir in the pediatric population. Safety and efficacy have not been established.


Geriatric


Although appropriate studies on the relationship of age to the effects of boceprevir have not been performed in the geriatric population, no geriatric-specific problems have been documented to date. However, elderly patients are more likely to have age-related liver problems, which may require caution in patients receiving boceprevir.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking boceprevir, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using boceprevir with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Alfuzosin

  • Carbamazepine

  • Cisapride

  • Colchicine

  • Dihydroergotamine

  • Drospirenone

  • Ergonovine

  • Ergotamine

  • Lovastatin

  • Methylergonovine

  • Midazolam

  • Phenobarbital

  • Phenytoin

  • Pimozide

  • Rifampin

  • Sildenafil

  • Simvastatin

  • St John's Wort

  • Tadalafil

  • Triazolam

Using boceprevir with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Alprazolam

  • Amiodarone

  • Bepridil

  • Budesonide

  • Dexamethasone

  • Digoxin

  • Efavirenz

  • Ethinyl Estradiol

  • Flecainide

  • Fluticasone

  • Itraconazole

  • Posaconazole

  • Propafenone

  • Quinidine

  • Rifabutin

  • Ruxolitinib

  • Salmeterol

  • Sirolimus

  • Sunitinib

  • Vardenafil

  • Voriconazole

Using boceprevir with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Ketoconazole

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of boceprevir. Make sure you tell your doctor if you have any other medical problems, especially:


  • Blood or bone marrow problems (e.g., anemia, neutropenia)—Use with caution. May make these conditions worse.

Proper Use of boceprevir


To help clear up your infection completely, boceprevir must be taken together with peginterferon alfa and ribavirin for the full time of treatment, even if you begin to feel better after a few days. Also, it is important to keep the amount of medicine in your body at a steady level. To help keep the amount constant, boceprevir must be used on a regular schedule.


Take boceprevir with a meal or light snack.


Do not change or suddenly stop using boceprevir without checking first with your doctor.


boceprevir should come with a Medication Guide. Read and follow the information carefully. Ask your doctor if you have any questions. Ask your pharmacist for the Medication Guide if you do not have one.


Dosing


The dose of boceprevir will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of boceprevir. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For hepatitis C virus infection, in combination with peginterferon alfa and ribavirin:
      • Adults—800 milligrams (mg) (four 200-mg capsules) three times a day with food. Each dose should be taken 7 to 9 hours apart.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of boceprevir, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


If you miss a dose or forget to use it, and it is less than 2 hours before your next regular dose, wait until then to take the medicine and skip the missed dose. If you miss a dose and it is more than 2 hours before your next regular dose, go ahead and take the missed dose and take the next regular dose as scheduled. If you have any questions about this, ask your pharmacist or doctor.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using boceprevir


It is very important that your doctor check your progress at regular visits to make sure boceprevir is working properly. Blood tests may be needed to check for unwanted effects.


Using boceprevir together with peginterferon alfa and ribavirin while you are pregnant can harm your unborn baby. These medicines may also cause birth defects if the father is using it when his sexual partner becomes pregnant. If a pregnancy occurs while you are using these medicines, tell your doctor right away.


To make sure you are not pregnant, your doctor may ask you to have a pregnancy test before you start using boceprevir. You must have a negative pregnancy test before you will be allowed to use boceprevir with ribavirin. Two forms of birth control must be used during treatment and for 6 months after treatment ends. You should test for pregnancy every month while you are using boceprevir, and for 6 months after your treatment ends.


Birth control pills may not work while you are using boceprevir. To keep from getting pregnant, use two other forms of birth control. Other forms of birth control include condoms, diaphragms, or contraceptive foams or jellies.


Do not use boceprevir together with the following medicines: alfuzosin (Uroxatral®), cisapride (Propulsid®), drospirenone (Yasmin®, Yaz®), oral midazolam (Versed®), pimozide (Orap®), rifampin (Rifadin®, Rimactane®), sildenafil (Revatio®), St. John's wort, tadalafil (Adcirca®), triazolam (Halcion®), certain medicines to lower cholesterol (such as lovastatin, simvastatin, Mevacor®, or Zocor®), medicines to treat seizures (such as carbamazepine, phenobarbital, phenytoin, Dilantin®, or Tegretol®), or ergot medicines (such as dihydroergotamine, ergonovine, ergotamine, methylergonovine, DHE 45®, Ergomar®, Ergotrate®, or Methergine®). Using boceprevir with any of these medicines can cause very serious medical problems.


Check with your doctor right away if you have back, leg, or stomach pains; bleeding gums; chills; dark urine; difficulty with breathing; fever; general body swelling; headache; loss of appetite; nausea or vomiting; nosebleeds; pale skin; sore throat; unusual tiredness or weakness; or yellowing of the eyes or skin. These could be symptoms of a blood disorder called anemia.


Birth control pills may not work while you are using boceprevir. To keep from getting pregnant, use two other forms of birth control. Other forms of birth control include condoms, diaphragms, or contraceptive foams or jellies.


Using boceprevir can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets in the blood, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

Make sure any doctor or dentist who treats you knows that you are using boceprevir. boceprevir may affect the results of certain medical tests.


boceprevir will not keep you from giving hepatitis C to other people. Follow your doctor's instructions about how to prevent the spread of this infection.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


boceprevir Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Black, tarry stools

  • chills

  • cough

  • difficult or labored breathing

  • fever

  • lower back or side pain

  • painful or difficult urination

  • pale skin

  • shortness of breath

  • sore throat

  • tightness in the chest

  • troubled breathing with exertion

  • ulcers, sores, or white spots in the mouth

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • wheezing

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Change in taste

  • decreased appetite

  • diarrhea

  • difficulty with moving

  • dizziness

  • dry mouth

  • dry skin

  • hair loss or thinning of the hair

  • irritability

  • lack or loss of strength

  • loss of taste

  • muscle pain or stiffness

  • nausea

  • pain in the joints

  • rash

  • sleeplessness

  • trouble sleeping

  • unable to sleep

  • vomiting

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

Friday, 6 February 2009

Diplexil




Diplexil may be available in the countries listed below.


Ingredient matches for Diplexil



Valproic Acid

Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Diplexil in the following countries:


  • Portugal

International Drug Name Search

Friday, 16 January 2009

Rislamid R




Rislamid R may be available in the countries listed below.


Ingredient matches for Rislamid R



Disopyramide

Disopyramide is reported as an ingredient of Rislamid R in the following countries:


  • Japan

International Drug Name Search

Wednesday, 7 January 2009

Kinetal




Kinetal may be available in the countries listed below.


Ingredient matches for Kinetal



Pentoxifylline

Pentoxifylline is reported as an ingredient of Kinetal in the following countries:


  • Latvia

International Drug Name Search

Symleptic




Symleptic may be available in the countries listed below.


Ingredient matches for Symleptic



Gabapentin

Gabapentin is reported as an ingredient of Symleptic in the following countries:


  • Poland

International Drug Name Search

Friday, 2 January 2009

Vancomicina Northia




Vancomicina Northia may be available in the countries listed below.


Ingredient matches for Vancomicina Northia



Vancomycin

Vancomycin is reported as an ingredient of Vancomicina Northia in the following countries:


  • Argentina

International Drug Name Search